Skip to main content

Table 3 Relative risk (RR) of cancer in offspring according to maternal hyperemesis gravidarum (HG)- status for selected types of cancer combined and separately, with 95 % confidence intervals (95 % CI)

From: Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case–control study

 

N

Cases

Controls

Crude RR (95 % CI)

Adjusted RR* (95 % CI)

Total

14.805

HG+ 97

HG+ 818

1.18 (0.95-1.46)

1.19 (0.97-1.48)

HG- 14.708

HG- 146.891

Leukemia

5.114

HG+ 28

HG+ 280

0.99 (0.67-1.47)

1.00 (0.68-1.48)

HG-5.086

HG- 50.845

Central nervous

4.524

HG+ 29

HG+ 242

1.20 (0.81-1.78)

1.24 (0.84-1.83)

system

HG- 4.495

HG- 45.026

Lymphoma

1.853

HG+ 15

HG+ 102

1.70 (0.98-2.96)

1.68 (0.97-2.92)

HG- 1.838

HG- 19.973

Testis

847

HG+ 4

HG+ 51

0.87 (0.31-2.43)

0.87 (0.31-2.43)

HG- 843

HG- 9.190

Nephroblastoma

441

HG+ 8

HG+ 48

1.97 (0.91-4.23)

2.01 (0.93-4.34)

HG- 433

HG- 4.850

Adrenal gland

417

HG+ 3

HG+ 28

1.12 (0.34-3.75)

1.14 (0.34-3.80)

HG- 414

HG- 4.567

Primary bone

394

HG+ 2

HG+ 15

1.40 (0.31-6.20)

1.38 (0.31-6.15)

HG-392

HG- 4.286

Retinoblastoma

345

HG+ 3

HG+ 36

0.97 (0.29-3.20)

0.97 (0.29-3.20)

HG- 342

HG- 3.725

Thyroid gland

343

HG+ 4

HG+ 21

2.11 (0.71-6.29)

2.21 (0.73-6.71)

 

HG- 339

HG- 3.836

Ovary

296

HG+ 1

HG+ 20

0.50 (0.07-3.72)

0.48 (0.06-3.62)

HG- 295

HG- 3.193

Hepatoblastoma

213

HG+ 0

HG+ 13

-

-

HG- 213

HG- 2.340

Breast

18

HG+ 0

HG+ 2

-

-

HG- 18

HG- 187

  1. *Adjusted for maternal age and maternal country of birth